Investors Overview
Webcast ImageWebcast
Q3 2018 Collegium Pharmaceutical Inc Earnings Conference Call (Live)
11/08/18 at 4:30 p.m. ET
Q3 2018 Collegium Pharmaceutical Inc Earnings Conference Call
Thursday, November 8, 2018 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases.

Collegium has developed a novel, patented, abuse-deterrent technology platform, DETERx®, designed to provide extended-release drug delivery, while safeguarding against common methods of abuse and tampering including crushing, chewing, heating and injecting.

Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the FDA for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. While abuse of Xtampza ER is still possible, FDA has determined that the product has abuse-deterrent properties. The Xtampza ER label supports alternate administration options, including, sprinkling the capsule contents on soft foods or into a cup, and then directly into the mouth, or through a gastrostomy or nasogastric feeding tube.

Stock Quote

COLL (Common Stock)
PriceChange% ChangeVolume
$16.49 + 0.090.55%102,827
Previous CloseToday's OpenIntraday HighIntraday Low
$16.40$16.48$16.73$15.97
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent News

More »
DateTitle 
10/17/18Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate UpdatePrinter Friendly Version
09/28/18Collegium to Present at Upcoming Investor ConferencePrinter Friendly Version
09/04/18Collegium Announces Scientific Presentations at PAINWeek 2018 MeetingPrinter Friendly Version

Upcoming Events

More »
DateTitle
11/08/18
4:30 p.m. ET
Q3 2018 Collegium Pharmaceutical Inc Earnings Conference Call